Advanced Search

Oncology Agents Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

SECTION HEADS

  • Photo of David Kerr

    David Kerr

    Department of Clinical Pharmacology, University of Oxford, Oxford, UK

  • Photo of Gilberto Schwartsmann

    Gilberto Schwartsmann

    CPG Clinica Medica da UFRGS, Hospital de Clinicas de Porto Alegre - UFRGS, Santa Cecília, Porto Alegre, Brazil

Section Topics

  • » Anti-angiogenic agents
  • » Anti-emetics & other drugs combating side effects
  • » Cancer gene therapies
  • » Cancer vaccines
  • » Cytokines
  • » Cytoxics
  • » Growth Factors
  • » Hormonal agents
  • » Monoclonal antibodies
  • » New agents (phase I + II trials) & novel combination therapies
  • » Other anti-neoplastic agents
  • » Other supportive care agents
  • » Signal transduction inhibitors

LATEST EVALUATION

Finally, there is an answer from the Chemotherapy in Early Stages Trial (CHEST) that focused on the value of three preoperative cycles of platinum-containing (gemcitabine/cisplatin) therapy followed by surgery and that studied the...

Nico van Zandwijk, University of Sydney, Australia. F1000 Respiratory Disorders

8 Must Read

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

6
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia.

Zwick C, Hartmann F, Zeynalova S, Pöschel V, ..., Schmitz N, Loeffler M, Pfreundschuh M, German High-Grade Non-Hodgkin Lymphoma Study Group. Ann Oncol. 2011 Aug; 22(8):1872-7

1 Evaluation, most recent by

Daniel Vorobiof and Keo Tabane, Sandton Oncology Center, South Africa. F1000 Oncology

  • New Finding
  • Clinical Trial

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.

Faculty of 1000